A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA From 2007–2013
- 1 September 2016
- journal article
- review article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 50 (5) , 639-647
Abstract
The European Union and the United States have different legal frameworks in place for pediatric drug development, which can potentially lead to different pKeywords
This publication has 2 references indexed in Scilit:
- Advances in Pediatric Pharmacology, Therapeutics, and ToxicologyAdvances in Pediatrics, 2014
- Fixed-Dose Combinations for Treatment of Type 2 Diabetes MellitusAdvances in Therapy, 2012